Attention-Deficit hyperactivity disorder (ADHD): Does new research support old concepts?

Journal of Child Neurology

Volumn 23, Issue 7, 2008, Pages 775-784

  Furman, Mary Lydia ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

ADHD; Attention deficit hyperactivity disorder; Stimulant

Indexed keywords

AMPHETAMINE; ATOMOXETINE; METHYLPHENIDATE; PSYCHOSTIMULANT AGENT;

ABNORMAL BEHAVIOR; ANOREXIA; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; BLOOD PRESSURE; CHILD GROWTH; COMORBIDITY; CONDUCT DISORDER; CONFLICT OF INTEREST; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG CHOICE; GENETIC RISK; HALLUCINATION; HEART RATE; HUMAN; LEARNING DISORDER; LISTLESSNESS; MEDLINE; MENTAL INSTABILITY; MOOD DISORDER; NAUSEA; NEUROPSYCHOLOGY; OPPOSITIONAL DEFIANT DISORDER; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; REVIEW; SIDE EFFECT; SOMNOLENCE; SUDDEN DEATH; TIC;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EVIDENCE-BASED MEDICINE; HUMANS; IMPULSIVE BEHAVIOR;

EID: 47349093604     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073808318059     Document Type: Review

References (141)

1. Stein RK Measurement of ADHD outcomes: Implications for future research. Ambul Pediatr. 2007;7:140-143.
2. Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS Prevalence, recognition and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med. 2007;161:857-864.
3. McDonagh MS, Peterson K., Dana T., Thakurta S. Drug class review on pharmacologic treatments for ADHD. Final Report. Oregon Evidence-based Practice Center, Oregon Health and Science University. http://www.ohsu.edu/drugeffectiveness/reports/documents/ ADHD%20Final%20Report%20Update%202.pdf. Published December 2007. Accessed January 12, 2008.
4. Breggin PR Questioning the treatment for ADHD. Science. 2001;291:595.
5. McGuiness D. Attention deficit disorder: The emperor's clothes, animal "pharm," and other fiction. In: Fisher S, Greenburg RP, eds. The Limits of Biological Treatments for Psychological Distress. Hillsdale, NJ: Lawrence Erlbaum; 1989: 151-187.
6. Timimi S. Naughty Boys: Anti-Social Behaviour, ADHD and the Role of Culture. Basingstoke, UK: Palgrave Macmillan; 2005.
7. Carey WB Is ADHD a valid disorder? In: Jensen PS, Cooper JR, eds. Attention Deficit Hyperactivity Disorder: State of the Science. Best Practices. Kingston, NJ: Civic Research Institute; 2002.
8. Furman L. What is attention-deficit/hyperactivity disorder (ADHD) ? J Child Neurol. 2005;20:994-1003.
9. Scheffler RM, Hinshaw SP, Modrek S., Levine P. The global market for ADHD medications. Health Aff. 2007;26:450-457.
10. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry. 1999;56:1073-1086.
11. MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: Changes in effectiveness and growth after the end of treatment. Pediatrics. 2004;113:762-769.
12. MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics. 2004; 113: 754-761.
13. Swanson JM, Hinshaw SP, Arnold LA, et al. Secondary evaluations of MTA 36-month outcomes: Propensity score and growth mixture model analyses. J Am Acad Child Adolesc Psychiatry. 2007;46:1003-1014.
14. Molina B., Flory K., Hinshaw SP, et al. Delinquent behavior and emerging substance use in the MTA at 36 months: Prevalence, course, and treatment effects. J Am Acad Child Adolesc Psychiatry. 2007;46:1028-1040.
15. Jensen PS, Arnold LE, Swanson JM, et al. 3-Year follow-up of the NIMH MTA study. J Am Acad Child Adolesc Psychiatry. 2007;46:989-1002.
16. Banerjee TD, Middleton F., Faraone SV Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatr. 2007;96:1269-1274.
17. Joseph J. Not in their genes: A critical view of the genetics of attention-deficit hyperactivity disorder. Dev Rev. 2000;20:539-567.
18. Joseph J. Problems in psychiatric genetic research: A reply to Faraone and Biederman. Dev Rev. 2000;20:582-593.
19. Joseph J. Adoption study of ADHD. J Am Acad Child Adolesc Psychiatry. 2002;41:1389-1391.
20. Joseph J. The Missing Gene: Psychiatry, Heredity, and the Fruitless Search for Genes. New York, NY: Algora; 2006.
21. Scarr S., Carter-Saltzman L. Twin method: Defense of a critical assumption. Behav Genet. 1979;9:527-542.
22. Kringlen E. Heredity and Environment in the Functional Psychoses: An Epidemiological-Clinical Study. Oslo, Norway: Univeritetsforlaget; 1967.
23. Faraone SV, Khan SA Candidate gene studies of attention-deficit/ hyperactivity disorder. J Clin Psychiatry. 2006;67(suppl8):13-20.
24. Elia J., Devoto M. ADHD genetics: 2007 update. Curr Psychiatry Rep. 2007;9:434-439.
25. Little J., Bradley L., Bray MS, et al. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol. 2002;156:300-310.
26. Waldman ID, Gizer IR The genetics of attention deficit hyperactivity disorder Clin Psychol Rev. 2006;26:396-432.
27. Risch N., Teng J. The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases I. DNA pooling. Genome Res. 1998;8:1273-1288.
28. Li D., Sham PC, Owen MJ, He L. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum Mol Genet. 2006;15:2276-2284.
29. Yang B., Chan RC, Jing J., Li T., Sham P., Chen RY A meta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 3′-UTR of dopamine transporter gene and attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2007;144:541-550.
30. Faraone SV, Khan SA Candidate gene studies of attention deficit/ hyperactivity disorder. J Clin Psychiatry. 2006;67(suppl8):13-20.
31. Doyle A., Willcutt EG, Seidman LJ, et al. Attention-deficit/ hyperactivity disorder endophenotypes. Biol Psychiatry. 2005;57:1324-1335.
32. Swanson JM, Kinsbourne M., Nigg J., et al. Etiologic subtypes of attention-deficit/hyperactivity disorder: Brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychol Rev. 2007;17:39-59.
33. Lahey BB, Pelham WE, Loney J., Lee SS, Willcutt E. Instability of the DSM-IV subtypes of ADHD from preschool through elementary school. Arch Gen Psychiatry. 2005;62:896-902.
34. Thatcher RW Maturation of the human frontal lobes: Physiological evidence for staging. Dev Neuropsychol. 1991;7:397-419.
35. Leo J., Cohen D. Broken brains or flawed studies? A critical review of ADHD neuroimaging research. J Mind Behav. 2003;24:29-56.
36. Barkley RA Attention-deficit/hyperactivity disorder, self-regulation, and time: Toward a more comprehensive theory. J Dev Behav Pediatr. 1997;18:271-279.
37. Castellanos FX, Lee PP, Sharp W., et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA. 2002;288:1740-1748.
38. Seidman LJ, Valera EM, Makris N. Advancing the neuro-science of ADHD, structural brain imaging of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57:1263-1272.
39. Castellanos FX, Sonuga-Barke EJS, Milham MP, Tannock R. Characterizing cognition in ADHD: Beyond executive dysfunction. Trends Cogn Sci. 2006;10:117-123.
40. Sanai N., Mirzadeh Z., Berger MS Functional outcome after language mapping for glioma resection. N Engl J Med. 2008;358:18-27.
41. Snyder SH Seeking god in the brain. N Engl J Med. 2008;358:6-7.
42. Rhodes SM, Coghill DR, Matthews K. Neuropsychological functioning in stimulant-näve boys with hyperkinetic disorder. Psychol Med. 2005;35:1109-1120.
43. Wilcutt EG Validity of the executive function theory of attention deficit/hyperactivity disorder: A meta-analytic review. Biol Psychiatry. 2005;57:1336-1446.
44. Nigg JT, Wilcutt EG, Doyle AE, Sonuga-Barke EJS. Causal heterogeneity in attention deficit/hyperactivity disorder: Do we need neuropsychological subtypes ? Biol Psychiatry. 2005;57:1224-1230.
45. Nigg JT Neuropsychologic theory and findings in attention-deficit/ hyperactivity disorder: The state of the field and salient challenges for the coming decade. Biol Psychiatry. 2005;57:1424-1435.
46. Solanto MV, Abikoff H., Sonuga-Barke E., et al. The ecological validity of delay aversion and response inhibition as measures of impulsivity in AD/HD: A supplement to the NIMH multimodal treatment study of AD/HD J Abnorm Child Psychol. 2001;29:215-228.
47. Zentall S., Zentall T. Optimal stimulation: A model of disordered activity and performance in normal and deviant children, Psychol Bull. 1983;94:446-471.
48. Denckla MB A theory and model of executive function: A neuropsychological perspective. In: Lyon GA, Krasnegor NA, eds. Attention, Memory and Executive Function. Baltimore, MD: Paul H. Brooks; 1983: 263-278.
49. Martinussen R., Tannock R. Working memory impairments in children with attention-deficit hyperactivity disorder with and without comorbid language learning disorders. J Clin Exp Neuropsychol. 2006;28:1073-1094.
50. Sonuga-Barke Ejs. Causal models of attention-deficit/hyperactivity disorder: From common simple deficits to multiple developmental pathways. Biol Psychiatry. 2005;57:1231-1238.
51. Wodka EL, Mahone EM, Blankner JG, et al. Evidence that response inhibition is a primary deficit in ADHD. J Clin Exp Neuropsychol. 2007;29:345-356.
52. Clore GL, Huntsinger JR How emotions inform judgement and regulate thought. Trends Cogn Sci. 2007;11:393-399.
53. Volkow ND, Wang GJ, Fowler JS, et al. Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. Am J Psychiatry. 2004;161:1173-1180.
54. Biederman J., Milberger S., Faraone SV, et al. Family-environment risk factors for attention deficit hyperactivity disorder: A test of Rutter's indicators of adversity. Arch Gen Psychiatry. 1995;52:464-470.
55. Biederman J., Faraone S., Milberger S., et al. Predictors of persistence and remission of ADHD into adolescence: Results from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry. 1996;35:343-351.
56. Chronis AM, Lahey BB, Pelham WE, Kipp HL, Baumann BL, Lee SS Psychopathology and substance abuse in parents of young children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2003;42:1424-1432.
57. Chronis AM, Lahey BB, Pelham WE, et al. Maternal depression and early positive parenting predict future conduct problems in young children with attention-deficit/hyperactivity disorder. Dev Psychol. 2007;43:70-82.
58. Connor DF, Edwards G., Fletcher KE, Baird J., Barkley RA, Steingard RJ Correlates of comorbid psychopathology in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2003;42:193-200.
59. Elgar FJ, Curtis LJ, McGrath PJ, Waschbusch DA, Stewart SH Antecedent-consequence conditions in maternal mood and child adjustment: a four-year cross-lagged study. J Clin Child Adolesc Psychol. 2003;42:362-374.
60. Fisher M. Parenting stress and the child with attention-deficit/ hyperactivity disorder. J Clin Child Psychol. 1990;19:337-346.
61. Johnson JG, Cohen P., Kasen S., Brooke JS Extensive television viewing and the development of attention and learning difficulties during adolescence. Arch Pediatr Adolesc Med. 2007;161:480-486.
62. Johnston C., Mash EJ Families of children with attention-deficit/ hyperactivity disorder: Review and recommendations for future research. Clin Child Fam Psychol Rev. 2001;4:183-207.
63. Siminoff E., Pickles A., Wood N., Gringras P., Chadwick O. ADHD symptoms in children with mild intellectual disability. J Am Acad Child Adolesc Psychiatry. 2007;46:591-600.
64. Antshel KM, Phillips MH, Gordon M., Barkley R., Faraone SV Is ADHD a valid disorder in children with intellectual delays ? Clin Psychol Rev. 2006;26:555-572.
65. Romano E., Tremblay RE, Farhat A., Côté S. Development and prediction of hyperactive symptoms from 2 to 7 years in a population-based sample. Pediatrics. 2006; 117: 2101-2109.
66. Pelham W. What should we treat and how should we treat it? Paper presented at: The Spectrum of Developmental Disabilities XXIX: ADHD-Beyond the Basics; March 28, 2007; Baltimore MD.
67. Pfiffner LJ, Yee Mikami A., Huang-Pollack C., Easterlin B., Zalecki C., McBurnett K. A randomized, controlled trial of integrated home-school behavioral treatment for ADHD, predominantly inattentive type. J Am Acad Child Adolesc Psychiatry. 2007;46:1041-1050.
68. Van den Hoofdakker B., van den Veen-Mulders L., Stema S., Emmelkamp P., Minderaa RB, Nauta M. Effectiveness of behavioral parent training for children with ADHD in routine clinical practice: A randomized clinical study. J Am Acad Child Adolesc Psychiatry. 2007;46:1263-1271.
69. Pliszka SR Psychiatric comorbidities in children with attention deficit hyperactivity disorder: Implications for management. Paediatr Drugs. 2003;5:741-50.
70. Dilsaver SC, Henderson-Fuller S., Akiskal HS Occult mood disorders in 104 consecutively presenting children referred for the treatment of attention-deficit/hyperactivity disorder in a community mental health clinic. J Clin Psychiatry. 2003;64:1170-1176.
71. Brown TE, ed. Attention-Deficit Disorders and Comorbidities in Children, Adolescents, and Adults. Washington, DC: American Psychiatric Press; 2000.
72. Butler SF, Arredondo DE, McCloskey V. Affective comorbidity in children and adolescents with attention deficit hyperactivity disorder. Ann Clin Psychiatry. 1995;7:51-55.
73. Wolraich ML, Hannah JN, Baumgaertel A., Brown J. Comparison of diagnostic criteria for attention deficit/hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry. 1996;35:319-324.
74. Wilens TE, Biederman J., Brown S., et al. Psychiatric comorbidity and functioning in clinically referred preschool children and school-age youth with ADHD. J Am Acad Child Adolesc Psychiatry. 2002;41:262-268.
75. Semrud-Clikeman M., Biederman J., Sprich-Buckminster S., Lehman BK, Faraone SV, Norman D. Comorbidity between ADDH and learning disability: a review and report in a clinically referred sample J Am Acad Child Adolesc Psychiatry. 1992;31:439-448.
76. Pliszka SR Patterns of psychiatric comorbidity with attention deficit/ hyperactivity disorder. Child Adolesc Psychiatry Clin N Am. 2000;9:525-540.
77. DelBello MP, Soutullo CA, Hendricks W., Niemeier RT, McElroy SL, Strakowski SM Prior stimulant treatment in adolescents with bipolar disorder: Association with age at onset. Bipolar Disord. 2001;3:53-57.
78. Furman E. What is depression in childhood? Child Anal. 1992;4:101-123.
79. Bhatia SK, Bhatia SC Childhood and adolescent depression. Am Fam Physician. 2007;75:73-80.
80. Pine DS, Cohen E., Cohen P., Brook J. Adolescent depressive symptoms as predictors of adult depression: Moodiness or mood disorder? Am J Psychiatry. 1999;156:133-135.
81. Coyle JT Depression and bipolar support alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in children and adolescents. J Am Acad Child Adolesc Psychiatry. 2003;42:1494-1503.
82. Compton SN Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: An evidence-based medicine review J Am Acad Child Adolesc Psychiatry. 2004;43:930-951.
83. Pine DS, Cohen P., Brook J. Adolescent fears as predictors of depression. Biol Psychiatry. 2001;50:721-724.
84. Ryan ND Diagnosing pediatric depression. Biol Psychiatry. 2001;49:1050-1054.
85. Lewinsohn PM, Rohde P., Seeley JR, Klein DN, Gotlib IH Natural course of adolescent major depressive disorder in a community sample: Predictors of recurrence in young adults. Am J Psychiatry. 2002;157:1584-1591.
86. Pliszka SR Effect of anxiety on cognition, behavior, and stimulant response in ADHD. J Am Acad Child Adolesc Psychiatry. 1989;28:882-887.
87. Goez H., Back-Bennet O., Zelnik N. Differential stimulant response on attention in children with comorbid anxiety and oppositional defiant disorder. J Child Neurol. 2007;22:538-542.
88. Bedard AC, Tannock R. Anxiety, methylphenidate response, and working memory in children with ADHD. J Atten Disord. 2008;11:546-557.
89. Barkley RA, Cunningham CE Do stimulant drugs improve the performance of hyperkinetic children? Clin Pediatr. 1978;17:85-92.
90. Douglas VI, Barr RG, O'Neill ME, Britton BG Short term effects of methylphenidate on the cognitive, learning and academic performance of children with attention deficit disorder in the laboratory and the classroom. J Child Psychol Psychiatry. 1986;27:191-211.
91. Bernstein GA, Carroll ME, Crosby RD, Perwein AR, Go FS, Benowitz NL Caffeine effects on learning, performance and anxiety in normal school-age children. J Am Acad Child Adolesc Psychiatry. 1994;33:407-415.
92. Rappaport JL, Buchsbaum MS, Zahn TP, Weingartner H., Ludlow C., Mikkelsen EJ Dextroamphetamine: Cognitive and behavioral effects in normal prepubertal boys. Science. 1978;199:560-563.
93. Rapport MD, Denney C., DuPaul GJ, Gardner MJ Attention deficit disorder and methylphenidate: Normalization rates, clinical effectiveness and response prediction in 76 children. J Am Acad Child Adolesc Psychiatry. 1994;33:882-893.
94. Rappaport JL, Buchsbaum MS, Weingartner H., Zahn TP, Ludlow C., Mikkelsen EJ Dextroamphetamine: Its cognitive and behavioral effects in normal and hyperactive boys and men. Arch Gen Psychiatry. 1980;37:933-943.
95. Rie HE, Rie ED, Stewart S., Ambuel JP Effects of ritalin on underachieving children: A replication. Am J Orthopsychiatry. 1976;46:313-322.
96. Rhodes SM, Coghill DR, Matthews K. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II-broader executive and non-executive domains. J Child Psychol Psychiatry. 2006; 47: 1184-1194.
97. Grizenko N., Bhat M., Schwartz G., Ter-Stepanian M., Joober R. Efficacy of methylphenidate in children with attention-deficit hyperactivity disorder and learning disabilities: A randomized crossover trial. J Psychiatry Neurosci. 2006;31:46-51.
98. Foorman BR, Breier JI, Fletcher JM Interventions aimed at improving reading success: An evidence-based approach. Dev Neuropsychol. 2003;24:613-639.
99. O'Connor RE, Harty KR, Fulmer D. Tiers of intervention in kindergarten through third grade. J Learn Disabil. 2005;38:532-538.
100. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4 th ed. Washington, DC: American Psychological Association; 1994.
101. Horwitz AV, Wakefield JC The Loss of Sadness. How Psychiatry Transformed Normal Sorrow into Depressive Disorder. New York, NY: Oxford University Press; 2007.
102. McHugh PR Book review: The loss of sadness. N Eng J Med. 2007;357:947.
103. Snyder SM, Hall JR, Cornwell SL, Quintana H. Review of clinical validation of ADHD behavior rating scales. Psychol Rep. 2006;99:363-378.
104. American Academy of Pediatrics Arizona Chapter. ADHD Toolkit. http://www.azaap.org/for-health-care-providers/adhd.aspx. Accessed January 26, 2008.
105. Van Landeghem K., Hess C. Children's mental health: An overview and key considerations for health system stakeholders. NICHM Issue Paper. National Institute for Health Care Management Foundation. http://www.nihcm.org/pdf/CMHReport-FINAL.pdf. Published February 2005. Accessed January 26, 2008.
106. Wolraich ML, Lambert W., Doffing MA, Bickman L., Simmons T., Worley K. Psychometric properties of the Vanderbilt ADHD diagnostic parent rating scale in a referred population. J Pediatr Psychol. 2003;28:559-567.
107. Wolraich ML, Lambert EW, Bickman L., Simmons T., Doffing MA, Worley KA Assessing the impact of parent and teacher agreement on diagnosing attention-deficit hyperactivity disorder. J Dev Behav Pediatr. 2004;25:41-47.
108. Shaffer D., Fisher P., Lucas CP, Dulcan MK, Schwab-Stone ME The NIMH Diagnostic Interview Schedule for Children Version IV (DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry. 2000; 39: 28-38.
109. Wolraich ML, Hannah JN, Baumgaertel A., Brown J. Comparison of diagnostic criteria for attention deficit/hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry. 1996;35:319-324.
110. Wolraich ML, Feurer I., Hannah JN, Pinnock TY, Baumgaertel A. Obtaining systematic teacher reports of disruptive behavior disorders utilizing DSM-IV. J Abnorm Child Psychol. 1998;26:141-152.
111. Wolraich ML, Hannah JN, Baumgaertel A., Feurer ID Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a county-wide sample. J Dev Behav Pediatr. 1998;19:162-168.
112. Leslie LK, Weckerly J., Plemmons D., Landsverk J., Eastman S. Implementing the American Academy of Pediatrics attention-deficit/ hyperactivity disorder diagnostic guidelines in primary care settings. Pediatrics. 2004;114:129-140.
113. Lahey BB, McBurnett K., Piacentini JC Agreement of parent and teacher rating scales with comprehensive clinical assessment of attention deficit disorder with hyperactivity. J Psychopathol Behav Assess. 1987;9:429-439.
114. Mitsis EM, McKay KE, Schulz KP, Newcorn JH, Halperin JM Parent-teacher concordance for DSM-IV attention-deficit/hyperactivity disorder in a clinic-referred sample. J Am Acad Child Adolesc Psychiatry. 2000;39:308-313.
115. Tripp G., Schaughency EA, Clarke B. Parent and teacher rating scales in the evaluation of attention-deficit hyperactivity disorder: Contribution to diagnosis and differential diagnosis in clinically referred children. J Dev Behav Pediatr. 2006;27:209-218.
116. Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ Long-term stimulant medication treatment of attention-deficit/ hyperactivity disorder: Results from a population-based study. J Dev Behav Pediatr. 2006;27:1-10.
117. Klimkeit E., Graham C., Lee P., Morling M., Russo D., Tonge B. Children should be seen and heard: Self-report of feelings and behaviours in primary-school-age children with ADHD. J Atten Disord. 2006;10:181-191.
118. Faraone S., Giefer E. Long-term effects of methylphenidate transdermal delivery system treatment of ADHD on growth. J Am Acad Child Adolesc Psychiatry. 2007;46:1138-1147.
119. Faraone SV, Biederman J., Monuteaux M., Spencer T. Long-term effects of extended-release mixed amphetamine salts treatment of attention-deficit/ hyperactivity disorder on growth. J Child Adolesc Psychopharmacol. 2005;15:191-202.
120. Spencer TJ, Faraone SV, Biederman J., et al. Does prolonged therapy with a long-acting stimulant suppress growth in children with ADHD ? J Am Acad Child Adolesc Psychiatry. 2006;45:527-537.
121. Swanson JM, Elliott GR, Greenhill LL, et al. Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J Am Acad Child Adolesc Psychiatry. 2007;46:1015-1027.
122. Charach A., Figueroa M., Chen S., Ickowicz A., Schachar R. Stimulant treatment over 5 years: Effects on growth. J Am Acad Child Adolesc Psychiatry. 2006;45:415-421.
123. Villalba M., Racoosin J. Follow up of AERS search identifying cases of sudden death occurring with drugs used for the treatment of attention deficit hyperactivity disorder (ADHD). Office of Drug Safety. http://www.fda.gov/OHRMS/DOCK-ETS/AC/06/briefing/ 2006-4210b_07_01_safetyreview.pdf. Published February 28, 2006. Accessed February 15, 2008.
124. Findling RL, Biederman J., Wilens TE, et al; for the SLI381.301 and. 302 Study Groups. Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children. J Pediatr. 2005;147:348-354.
125. Israeli E., Schochat T., Korzets Z., Tekes-Manova D., Bernheim J., Golan E. Prehypertension and obesity in adolescents: A population study. Am J Hypertens. 2006;19:708-712.
126. Julius S. Blood pressure lowering only or more? Has the jury reached its verdict? Am J Cardiol. 2007;100:32J-37J.
127. Assessing the safety of ADHD medications. CME-Certified Monograph. Medical Crossfire/Liberty Communications Network. Vol. 7. http://www.medicalcrossfire.com/ADHD.pdf. Published October 2006. Accessed February 15, 2008.
128. American Academy of Pediatrics. What is ADHD Anyway? Questions from Teens [Trifold brochure]. Elk Grove Village, IL: American Academy of Pediatrics; 2005.
129. Child and Adults with attention-deficit/hyperactivity disorder income and expenditures 2006-2007. http://www.chadd.org/AM/Template.cfm?Section= Reports1&Template=/CM/ContentDisplay.cfm&ContentID=5148. Accessed February 11, 2008.
130. Cosgrove L., Krimsky S., Vijayaraghavan M., Schneider L. Financial ties between DSM-IV panel members and the pharmaceutical industry. Psychother Psychosom. 2006;75:154-160.
131. Okie S. ADHD in adults. N Engl J Med. 2006;354:2637-2644.
132. Babcock L., Loewenstein G. Explaining bargaining impasse: The role of self-serving biases. J Econ Perspect. 1997;11:109-126.
133. Katz D., Caplan AL, Merz JF All gifts large and small: Toward an understanding of the ethics of pharmaceutical industry gift-giving. Am J Bioeth. 2003;3:39-46.
134. Tungaraza T., Poole R. Influence of drug company authorship and sponsorship on drug trial outcomes. Br J Psychiatry. 2007;191:82-83.
135. Perlis RH, Perlis CS, WuY., Hwang C., Joseph M., Nierenberg AA Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. Am J Psychiatry. 2005;162:1957-1960.
136. Lesser LI, Ebbeling CB, Goozner M., Wypij D., Ludwig DS Relationship between funding source and conclusion among nutrition-related scientific articles. PLoS Med. 2007;4:e5.
137. Procyshyn RM, Chau A., Fortin P., Jenkins W. Prevalence and outcomes of pharmaceutical industry-sponsored clinical trials involving clozapine, risperidone, or olanzapine. Can J Psychiatry. 2004;49:601-606.
138. Turner EH, Matthews AM, Lindartos E., Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358:252-260.
139. Lexchin J. Interactions between physicians and the pharmaceutical industry: What does the literature say ? CMAJ. 1993;149:1401-1407.
140. Brennan TA, Rothman DJ, Blank L., et al. Health industry practices that create conflicts of interest: A policy proposal for academic medical centers. JAMA. 2006;295:429-433.
141. Campbell EG, Weissman JS, Ehringhaus S., et al. Institutional academic-industry relationships. JAMA. 2007;298:1779-1786.